摘要
目的:为中药注射剂的临床合理使用提供参考。方法:采用销售金额、用药频度(DDDs)、日均费用(DDC)和排序比(B/A)为指标的分析方法,对重庆地区39家医院2012-2014年中药注射剂的数据资料进行统计分析。结果:重庆地区39家医院2012-2014年中药注射剂总销售金额呈缓慢增长趋势,由76 758.10万元增加至91 175.90万元,年均增长率为8.98%;药品销售金额排名前10位之和为132 601.97万元,占总销售金额的51.11%。红花注射液和参芎葡萄糖注射液各年度销售金额均居前2位。血塞通注射液、参芎葡萄糖注射液、红花注射液和疏血通注射液各年度DDDs均居前4位。血必净注射液和康莱特注射液各年度DDC均排在第1、2位。销售金额排名前10位的中药注射剂中,B/A大多数<1.00;接近或等于1.00的有疏血通注射液、醒脑静注射液、参芎葡萄糖注射液和血栓通注射液;B/A始终>1.00的仅有血塞通注射液。结论:重庆地区39家医院2012-2014年中药注射剂应用总体增长速度平稳,用药集中于抗肿瘤和心脑血管疾病类,医师用药的合理性逐步提高。
OBJECTIVE：To provide reference for ration use of TCM injection. METHODS：The utilization of TCM injections in 39 hospitals from Chongqing area during 2012-2014 was analyzed statistically in respects of consumption sum,DDDs,DDC and B/A. RESULTS：The total consumption sum of TCM injections increased slowly in 39 hospitals from Chongqing area during2012-2014,increasing from 767 581 thousand yuan to 911 759 thousand yuan,with annual growth rate of 8.98%. Total sum of consumption sum of top 10 drugs was 1 326 019.7 thousand yuan,accounting for 51.11% of total. The consumption sum of Honghua injection and Shenxiong glucose injection always took up the first 2 places in those years. DDDs of Xuesaitong injection,Shenxiong glucose injection glucose,Honghua injection and Shuxuetong injection always took up the first 4 places in those years.DDC of Xuebijing injection and Kanglaite injection always took up the first and second places in those years. Among top 10 TCM injection in the list of consumption sum,most of B/A was lower than 1.00;B/A of Shuxuetong injection,Xingnaojing injection,Shenqiong glucose injection and Xueshuantong injection were close or equal to 1.00. Xuesaitong injection was the one that B/A1.00 from beginning to end. CONCLUSIONS：Total use of TCM injection increased steadily and drug use relatively concentrated in39 hospitals from Chongqing area during 2012-2014,and rationality of drug use by physicians had been improved gradually.
出处
《中国药房》
CAS
北大核心
2016年第23期3184-3187,共4页
China Pharmacy
